{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2009/note",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2009/note.json",
  "legislation": "ukdsi/2009/9780111486610",
  "legislation_title": "The Misuse of Drugs Act 1971 (Amendment) Order 2009",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2009",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Order)\nThis Order adds synthetic cannabinoid receptor agonists to Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 (“the Act”) which specifies drugs which are subject to control as Class B drugs under the Act. In addition, the Order adds Gamma-butyrolactone (GBL), 1,4–butanediol (1,4–BD), 15 anabolic steroids, two non-steroidal agents, Oripavine, 1–benzylpiperazine (BZP) and a group of substituted piperazines to Part 3 of Schedule 2 to the Act which specifies drugs which are subject to control as Class C drugs under the Act.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2009/9780111486610/note",
    "retrieved_at": "2026-10-30T14:56:42.694275+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}